<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>ETF Trends &#187; IHE</title>
	<atom:link href="http://www.etftrends.com/tag/ihe/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.etftrends.com</link>
	<description>Setting the Pace for Exchange Traded Funds</description>
	<lastBuildDate>Sat, 11 Feb 2012 14:09:57 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Utilities, Consumer and Pharma ETFs Lead 2011</title>
		<link>http://www.etftrends.com/2011/12/utilities-consumer-and-pharma-etfs-lead-2011/</link>
		<comments>http://www.etftrends.com/2011/12/utilities-consumer-and-pharma-etfs-lead-2011/#comments</comments>
		<pubDate>Mon, 19 Dec 2011 12:31:29 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[Feature Stories]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Consumer Staples]]></category>
		<category><![CDATA[IHE]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[PJP]]></category>
		<category><![CDATA[Utilities]]></category>
		<category><![CDATA[VDC]]></category>
		<category><![CDATA[XLP]]></category>
		<category><![CDATA[XLU]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=71788</guid>
		<description><![CDATA[Disruptions in the global economy have kept international equities suppressed, with a devastating Japanese earthquake crippling the normal supply chain between the Asia economies and escalating concerns over the Eurozone financial debt crisis. However, investors who opted to stick it out in domestic equity markets and exchange traded funds fared much better.
According to an S&#38;P [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2011/12/utilities-consumer-and-pharma-etfs-lead-2011/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Sector ETF Performance in 2011</title>
		<link>http://www.etftrends.com/2011/11/sector-etf-performance-in-2011/</link>
		<comments>http://www.etftrends.com/2011/11/sector-etf-performance-in-2011/#comments</comments>
		<pubDate>Sun, 06 Nov 2011 12:00:12 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[IHE]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Utilities]]></category>
		<category><![CDATA[XLU]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=68901</guid>
		<description><![CDATA[This year has been tough on stock exchange traded funds, especially those that track foreign markets, but Standard &#38; Poor&#8217;s believes domestic equity-based ETFs could weather the European debt storm.
Of the more than 1,000 exchange traded products available, only 192 ETFs are showing gains for the first 10 months of the year and only nine [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2011/11/sector-etf-performance-in-2011/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Lower-Risk Stock ETFs to Consider</title>
		<link>http://www.etftrends.com/2011/07/lower-risk-stock-etfs-to-consider/</link>
		<comments>http://www.etftrends.com/2011/07/lower-risk-stock-etfs-to-consider/#comments</comments>
		<pubDate>Mon, 25 Jul 2011 18:17:30 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[ETF 101]]></category>
		<category><![CDATA[Consumer Staples]]></category>
		<category><![CDATA[DXJ]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[IHE]]></category>
		<category><![CDATA[Utilities]]></category>
		<category><![CDATA[VDC]]></category>
		<category><![CDATA[VPU]]></category>
		<category><![CDATA[XLP]]></category>
		<category><![CDATA[XLU]]></category>
		<category><![CDATA[XLV]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=58975</guid>
		<description><![CDATA[Investors worried about choppy global economic growth and debt turmoil on both sides of Atlantic have been favoring exchange traded funds tracking traditionally defensive sectors such as healthcare, consumer staples and utilities.
Standard &#38; Poor’s equity analyst Tom Graves in a note Monday listed seven attractive equity ETFs with relatively low risk. [Investors Shift Into Defensive [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2011/07/lower-risk-stock-etfs-to-consider/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Biotech ETFs: Orexigen Hit By Regulatory Hammer</title>
		<link>http://www.etftrends.com/2011/06/biotech-etfs-orexigen-hit-by-regulatory-hammer/</link>
		<comments>http://www.etftrends.com/2011/06/biotech-etfs-orexigen-hit-by-regulatory-hammer/#comments</comments>
		<pubDate>Fri, 03 Jun 2011 19:47:41 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[FBT]]></category>
		<category><![CDATA[IBB]]></category>
		<category><![CDATA[IHE]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[PPH]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=55162</guid>
		<description><![CDATA[Biotech sector and related exchange traded funds (ETFs) trade lower as one drug maker garners notoriety after regulatory hurdles puts a hold on the advancement of an anticipated diet pill.

iShares Nasdaq Biotechnology (NYSEArca: IBB) is down 0.83%.
First Trust Amex Biotech Index Fund (NYSEAca: FBT) is down 0.74%.
iShares Dow Jones U.S. Pharmaceutical Index Fund (NYSEArca: IHE) [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2011/06/biotech-etfs-orexigen-hit-by-regulatory-hammer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Healthcare, Pharma ETFs Hit by Pfizer Decline</title>
		<link>http://www.etftrends.com/2011/05/healthcare-pharma-etfs-hit-by-pfizer-decline/</link>
		<comments>http://www.etftrends.com/2011/05/healthcare-pharma-etfs-hit-by-pfizer-decline/#comments</comments>
		<pubDate>Tue, 03 May 2011 15:59:08 +0000</pubDate>
		<dc:creator>John Spence</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[IHE]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[XLV]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=52706</guid>
		<description><![CDATA[A nearly 3% pullback in Pfizer (NYSE: PFE) after the drug giant reported flat quarterly revenue pulled down exchange traded funds (ETFs) that track healthcare and pharmaceuticals stocks on Tuesday.
“Excluding the impact of foreign exchange rates, total sales fell 1% year over year as patent losses weighed on overall growth,” said Morningstar analyst Damien Conover [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2011/05/healthcare-pharma-etfs-hit-by-pfizer-decline/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pfizer to Weigh on Pharma, Healthcare ETFs</title>
		<link>http://www.etftrends.com/2011/05/pfizer-to-weigh-on-pharma-healthcare-etfs/</link>
		<comments>http://www.etftrends.com/2011/05/pfizer-to-weigh-on-pharma-healthcare-etfs/#comments</comments>
		<pubDate>Tue, 03 May 2011 11:54:47 +0000</pubDate>
		<dc:creator>John Spence</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[IHE]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[XLV]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=52667</guid>
		<description><![CDATA[Healthcare exchange traded funds (ETFs) will face an uphill climb Tuesday following quarterly results from top holding Pfizer (NYSE: PFE), which saw its shares fall over 1% in premarket trading.
Pfizer’s adjusted net income topped expectations and the drug maker reiterated its 2011 outlook. Chief Executive Ian Read said the firm expects to complete an evaluation [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2011/05/pfizer-to-weigh-on-pharma-healthcare-etfs/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pharma, Healthcare ETFs in Focus on M&amp;A Talk, Earnings</title>
		<link>http://www.etftrends.com/2011/04/pharma-healthcare-etfs-in-focus-on-ma-talk-earnings/</link>
		<comments>http://www.etftrends.com/2011/04/pharma-healthcare-etfs-in-focus-on-ma-talk-earnings/#comments</comments>
		<pubDate>Mon, 18 Apr 2011 12:29:29 +0000</pubDate>
		<dc:creator>John Spence</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[IHE]]></category>
		<category><![CDATA[IYH]]></category>
		<category><![CDATA[Lead]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[PPH]]></category>
		<category><![CDATA[VHT]]></category>
		<category><![CDATA[XLV]]></category>
		<category><![CDATA[XPH]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=51139</guid>
		<description><![CDATA[Exchange traded funds (ETFs) tracking pharmaceutical and healthcare stocks could see action Monday on news Johnson &#38; Johnson (NYSE: JNJ) is on the prowl for acquisitions and earnings from Eli Lilly (NYSE: LLY).
Swiss device maker Synthes confirmed it is in merger negotiations with J&#38;J, according to reports. Shares of U.K. medical technology company Smith &#38; [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2011/04/pharma-healthcare-etfs-in-focus-on-ma-talk-earnings/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>ETFs React to Strong Retail Sales, Egypt Clashes</title>
		<link>http://www.etftrends.com/2011/02/etfs-react-strong-retail-sales-egypt-clashes/</link>
		<comments>http://www.etftrends.com/2011/02/etfs-react-strong-retail-sales-egypt-clashes/#comments</comments>
		<pubDate>Thu, 03 Feb 2011 16:30:39 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[Hot Story]]></category>
		<category><![CDATA[IHE]]></category>
		<category><![CDATA[Industrial Metals]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[PRN]]></category>
		<category><![CDATA[Retail]]></category>
		<category><![CDATA[VAW]]></category>
		<category><![CDATA[XRT]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=45899</guid>
		<description><![CDATA[Despite a dip in jobless claims, strong retail sales, rising factory orders and a spate of positive earnings reports, stocks and exchange traded funds (ETFs) turned negative at the market&#8217;s open.

New U.S. claims for unemployment benefits dropped more than expected last week, a government report showed on Thursday, pointing to continued gradual improvement in the [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2011/02/etfs-react-strong-retail-sales-egypt-clashes/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>ETFs Nearly Erase Friday&#8217;s Losses</title>
		<link>http://www.etftrends.com/2011/02/etfs-nearly-erase-fridays-losses/</link>
		<comments>http://www.etftrends.com/2011/02/etfs-nearly-erase-fridays-losses/#comments</comments>
		<pubDate>Tue, 01 Feb 2011 16:30:24 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Commodity ETFs]]></category>
		<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[Global ETFs]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Africa]]></category>
		<category><![CDATA[Airlines]]></category>
		<category><![CDATA[EGPT]]></category>
		<category><![CDATA[Egypt]]></category>
		<category><![CDATA[Emerging Markets]]></category>
		<category><![CDATA[Energy]]></category>
		<category><![CDATA[FAA]]></category>
		<category><![CDATA[Frontier Markets]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[IHE]]></category>
		<category><![CDATA[Industrial Metals]]></category>
		<category><![CDATA[Middle East]]></category>
		<category><![CDATA[Oil]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Transportation]]></category>
		<category><![CDATA[USO]]></category>
		<category><![CDATA[VIS]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=45707</guid>
		<description><![CDATA[Stocks and exchange traded funds (ETFs) were undaunted by an intensifying revolution in Egypt, emboldened by manufacturing data and a continuation of the strong fourth-quarter earnings seen in recent weeks.

The U.S. manufacturing sector grew at the fastest rate in almost seven years last month. The growth bodes well for the continued advancement of the economy. [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2011/02/etfs-nearly-erase-fridays-losses/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pharmaceutical ETFs Look to the Future</title>
		<link>http://www.etftrends.com/2011/01/pharmaceutical-etfs-look-future/</link>
		<comments>http://www.etftrends.com/2011/01/pharmaceutical-etfs-look-future/#comments</comments>
		<pubDate>Sat, 29 Jan 2011 09:00:35 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[EIS]]></category>
		<category><![CDATA[Emerging Markets]]></category>
		<category><![CDATA[Global ETFs]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[Hot Story]]></category>
		<category><![CDATA[IHE]]></category>
		<category><![CDATA[Israel]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[PJP]]></category>
		<category><![CDATA[XPH]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=45261</guid>
		<description><![CDATA[Pharmaceutical exchange traded funds (ETFs) are poised to come roaring back after a lackluster 2010. Just say&#8230;yes?
Last year, pharma underperformed as economic crisis and high joblessness led people to cut back on &#8220;non-essentials.&#8221; Unfortunately, prescriptions often got lumped into that class. Cost-consciousness will likely persist, but therein lies the opportunity.

Americans are forecast to fill up [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2011/01/pharmaceutical-etfs-look-future/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Health Care ETFs Jump As Changes Kick In</title>
		<link>http://www.etftrends.com/2011/01/health-care-etfs-jump-changes-kick/</link>
		<comments>http://www.etftrends.com/2011/01/health-care-etfs-jump-changes-kick/#comments</comments>
		<pubDate>Tue, 04 Jan 2011 14:00:57 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[FXH]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[Hot Story]]></category>
		<category><![CDATA[IHE]]></category>
		<category><![CDATA[IHF]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[PJP]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=44063</guid>
		<description><![CDATA[As the calendar switched over into the new year, a slew of new health care rules went into effect. Health care exchange traded funds (ETFs) kicked off the year trading higher, but whether that sticks is another story.
Janet Adamy for The Wall Street Journal reports that new taxes on drug makers, lower prescription-drug costs for [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2011/01/health-care-etfs-jump-changes-kick/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Play the Booming Biotech Sector With ETFs</title>
		<link>http://www.etftrends.com/2010/12/play-booming-biotech-sector-etfs/</link>
		<comments>http://www.etftrends.com/2010/12/play-booming-biotech-sector-etfs/#comments</comments>
		<pubDate>Tue, 21 Dec 2010 23:00:29 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[BBH]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[Hot Story]]></category>
		<category><![CDATA[IBB]]></category>
		<category><![CDATA[IHE]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[XBI]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=43168</guid>
		<description><![CDATA[Economic downturn? What economic downturn? Despite lackluster economic growth, biotechnology exchange traded funds (ETFs) have managed to notch solid performance this year.
In the United Kingdom alone, the bioscience sector has exploded. It now includes 942 companies, with 345 involved in the development, manufacture or sales of therapeutic products, according to PharmaLive. The biotech sector also [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2010/12/play-booming-biotech-sector-etfs/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pharmaceutical ETFs: Drug Companies Roar Back</title>
		<link>http://www.etftrends.com/2010/11/pharmaceutical-etfs-drug-companies-roar-back/</link>
		<comments>http://www.etftrends.com/2010/11/pharmaceutical-etfs-drug-companies-roar-back/#comments</comments>
		<pubDate>Tue, 16 Nov 2010 19:00:59 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[IHE]]></category>
		<category><![CDATA[Lead]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[PJP]]></category>
		<category><![CDATA[XPH]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=41339</guid>
		<description><![CDATA[Back in the day, Big Pharma&#8217;s block buster drugs were their bread and butter, but those patents are running out. However, the industry&#8217;s fortunes could be turning as new breakthroughs bring pharma companies and related exchange traded funds (ETFs) back from the brink.
Some cases in point:

Bayer and Johnson &#38; Johnson (NYSE: JNJ) have come up [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2010/11/pharmaceutical-etfs-drug-companies-roar-back/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pharma ETFs Find New Avenues of Growth</title>
		<link>http://www.etftrends.com/2010/10/pharma-etfs-find-new-avenues-of-growth/</link>
		<comments>http://www.etftrends.com/2010/10/pharma-etfs-find-new-avenues-of-growth/#comments</comments>
		<pubDate>Fri, 08 Oct 2010 21:00:10 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[Hot Story]]></category>
		<category><![CDATA[IHE]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[PJP]]></category>
		<category><![CDATA[XPH]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=38930</guid>
		<description><![CDATA[Big pharma has been sitting on a cash cow for years, but patents for iconic drugs are nearing expiration. As cheaper generics become mass produced in emerging markets, the pharmaceutical exchange traded funds (ETFs) may mirror the new area of growth for the pharma industry.
Prescription-tracker IMS Health projects that global pharmaceutical sales will increase by [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2010/10/pharma-etfs-find-new-avenues-of-growth/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Health Care ETFs: Next Up, Emerging Markets</title>
		<link>http://www.etftrends.com/2010/08/health-care-etfs-next-up-emerging-markets/</link>
		<comments>http://www.etftrends.com/2010/08/health-care-etfs-next-up-emerging-markets/#comments</comments>
		<pubDate>Mon, 30 Aug 2010 22:00:49 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[Global ETFs]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Emerging Markets]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[IHE]]></category>
		<category><![CDATA[IXJ]]></category>
		<category><![CDATA[PJP]]></category>
		<category><![CDATA[VHT]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=36323</guid>
		<description><![CDATA[Citizens of developing countries are getting richer. That newfound wealth is a major opportunity for health care exchange traded funds (ETFs), and that fact hasn&#8217;t been lost on big pharma.
As the emerging market middle class grows, so will health care resources and companies. Kevin Grewal for Seeking Alpha reports that a report released by UBS [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2010/08/health-care-etfs-next-up-emerging-markets/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

